opioid-use-disorder

Documents about opioid-use-disorder

• Establishing Efficacy of a Functional-Restoration Based CAM Pain Management Program in Post-9/11 Veterans#836087ClinicalTrials.gov
• Vanderbilt Integrated Community TMS for Opioid Recovery (VICTORY): Study protocol for a randomized, controlled trial of non-invasive brain stimulation to reduce craving in people with opioid use disorder#682329bioRxiv / medRxiv
• Hospital readmissions and emergency department encounters among patients who initiate medications for opioid use disorder during hospitalization: Comparison of patients with and without co-occurring methamphetamine use.#415589NCBI PubMed Central
• Collaboration Leading to Addiction Treatment and Recovery From Other Stresses#993183ClinicalTrials.gov
• Would we, could we? Measuring attitudinal and capacity barriers to supporting recovery housing residents on medication for opioid use disorder.#269420NCBI PubMed Central
• Emergency Department Visits, Inpatient Hospitalizations, and Nonfatal and Fatal Drug Overdoses During COVID-19 Among Veterans With Opioid Use Disorder.#327191NCBI PubMed Central
• Adaption of a posttraumatic stress disorder intervention for patients who use stimulants and opioids in the opioid treatment programme setting.#358341NCBI PubMed Central
• Single Dose Study of [14C]-IDV184001AN ([14C]-IDV184001) in Healthy Adult Male Participants#803164ClinicalTrials.gov
• Adaption of a posttraumatic stress disorder intervention for patients who use stimulants and opioids in the opioid treatment programme setting.#351949PubMed
• Evaluation of Switch to Dolutegravir/Lamivudine (DTG/3TC) From Current Suppressive Antiretroviral Therapy in People Living With HIV (PLWH) Receiving Opioid Agonist Therapy (OAT)#909345ClinicalTrials.gov
• "Stigma is our most powerful enemy": Understanding opioid use disorder stigma and the role of peer support in rural Maryland.#565NCBI PubMed Central
• A lifeline on wheels: perspectives of stakeholders on the implementation and impact of a mobile medications for opioid use disorder unit.#13679NCBI PubMed Central
• Mediation of chronic pain and disability on opioid use disorder risk by pain management practices among adult Medicaid patients, 2016-2019.#351738NCBI PubMed Central
• Leveraging Regulatory Flexibility for Methadone Take-Home Dosing to Improve Retention in Treatment for Opioid Use Disorder#869985ClinicalTrials.gov
• Improving Social Connectedness Through Digital Health to Enhance Recovery From OUD Among the Justice Involved Population#873100ClinicalTrials.gov
• Randomized Trial of ACT and a Care Management App in Primary Care-based Buprenorphine Treatment#900335ClinicalTrials.gov
• Ending Transmission of HIV, HCV, and STDs and Overdose in Rural Communities of People Who Inject Drugs (ETHIC)#861883ClinicalTrials.gov
• Technology-Enhanced Therapy vs. Medication Monitoring for Buprenorphine Retention in Pregnant Persons#903244ClinicalTrials.gov
• Longitudinal academic achievement in children with a history of neonatal abstinence syndrome: a retrospective observational cohort study#5223Europe PMC
• "We're All in This Together": A Mixed-Methods Study of Provider and Patient Perceptions of Emergency Care for Opioid Use Disorder.#263017NCBI PubMed Central
• Predicting Early Non-Response to Buprenorphine Treatment for Opioid Use Disorder: A Machine Learning Approach#341073OSF
• KIOS Mobile App Evaluation#918760ClinicalTrials.gov
• Rationale and design of a three-arm randomized clinical trial to improve drug use and retention in care of people with opioid use disorder on buprenorphine: OVERCOME II study.#351735NCBI PubMed Central
• State Policy Variation in Implementation of Federal Drug and Child Abuse Laws and Stigmatization of Pregnant and Postpartum Individuals with Opioid Use Disorder.#140798NCBI PubMed Central
• Characterizing complex opioid use disorder care trajectories and outcomes following acute service utilization: A protocol for a population-based data linkage study.#148175NCBI PubMed Central
• New data on opioid use disorder and risk of overdose in adolescent and young adult disease-free survivors prescribed opioids after cancer treatment.#247524NCBI PubMed Central
• Genome-Wide Association Studies and Deep-Learning Functional Annotation of Opioid Use Disorder across Three Ancestries in the All of Us Research Program#456623bioRxiv / medRxiv
• National Trends and State-Level Correlates of Medications for Opioid Use Disorder Utilization Among Treatment Admissions in the United States, 2014-2023#654837Scholars Crossing
• The O'Neil Long Acting Naltrexone Implant (OLANI) Pharmacokinetic (PK)/Safety Study in Healthy Volunteers#866496ClinicalTrials.gov
• Comparative effectiveness of preferred pharmacological treatment options for bipolar disorder among people with opioid use disorder in British Columbia and Ontario, Canada: protocol for parallel population-based target trial emulations#150417bioRxiv / medRxiv
• Comparative effectiveness of preferred pharmacological treatment options for bipolar disorder among people with opioid use disorder in British Columbia and Ontario, Canada: protocol for parallel population-based target trial emulations#152063Unpaywall
• Community-level perceptions of housing services for people with opioid use disorder: a qualitative analysis of community stakeholders in the HEALing communities study.#25882NCBI PubMed Central
• Reimbursement Potential of Collaborative Care Model (CoCM) Billing Codes for Opioid Use Disorder Co-Occurring with Mental Disorders: Descriptive Estimates from a Pragmatic Trial.#251201NCBI PubMed Central
• Long‐Acting Naltrexone Restores Network Connectivity in Subjects With Comorbid Cannabis and Opioid Use Disorder#485349Europe PMC
• Superficial Parasternal Intercostal Plane Block in Cardiac Surgery Trial#826832ClinicalTrials.gov
• Reducing Overdose and Substance Use-related Stigma by Training Non-substance-using Friends and Family Members of People Who Use Opioids to Be Harm Reduction Champions#909634ClinicalTrials.gov
• Subgroup identification of disparities in buprenorphine discontinuation in opioid-use disorder: A Virtual Twins machine learning approach using nationwide United States claims data, 2006-2022.#1085NCBI PubMed Central
• A Mediation Model Approach to Uncover Risk Mechanisms and Treatment Barriers for Females in Rural Area#11957DataCite
• Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment#871713ClinicalTrials.gov
• Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study#810371ClinicalTrials.gov
• Continuum of care in hospitalized patients with opioid or stimulant use disorder and infectious complications of drug use-substance use/infectious disease integrated clinic compared to treatment as usual to prevent infection-related readmission (CHOICE-STAR): a study protocol for an effectiveness-implementation randomized controlled trial.#660NCBI PubMed Central
• Implementation of an opioid use disorder (OUD) machine-learning phenotype in real-time for the ADAPT clinical trial#646446PLOS
• Scalable Digital Delivery of Evidence-based Training for Family to Maximize Treatment Admission Rates of Opioid Use Disorder in Loved Ones#895831ClinicalTrials.gov
• Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products#905117ClinicalTrials.gov
• Characterizing complex opioid use disorder care trajectories and outcomes following acute service utilization: A protocol for a population-based data linkage study#146555PLOS
• Economic considerations of office-based methadone as an opioid use disorder treatment option: a cost-effectiveness analysis and methodological comparison#156482Springer Nature OA
• Treatment characteristics and safety profiles of Belbuca®, buprenorphine patch, and oral schedule II opioids among chronic low back pain patients without a positive history of opioid-use disorder: a retrospective US commercial claims analysis.#371563NCBI PubMed Central
• Toward Fairness in Machine Learning Models for Predicting Treatment Retention and Premature Discontinuation in Medication for Opioid Use Disorder#483881Springer Nature OA
• Participatory System Dynamics vs Usual Quality Improvement: Staff Use of Simulation as an Effective, Scalable and Affordable Way to Improve Timely Mental Health Care?#1031650ClinicalTrials.gov
• Retention and Re-Engagement in Treatment for Addiction Following Serious Injection Related Infections (RETAIN)#982559ClinicalTrials.gov